The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer.

被引：0
|
作者：
Salari, Keyan
Zlatev, Dimitar V.
Kuppermann, David
Preston, Mark A.
Dahl, Douglas M.
Efstathiou, Jason A.
Blute, Michael L.
Zietman, Anthony L.
Feldman, Adam S.
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.76
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Risk of progression following a negative biopsy in prostate cancer active surveillance
    Kerri Beckmann
    Aida Santaolalla
    Mikio Sugimoto
    Peter Carroll
    Jose Rubio
    Arnauld Villers
    Anders Bjartell
    Todd Morgan
    Prokar Dasgupta
    Mieke Van Hemelrijck
    Oussama Elhage
    [J]. Prostate Cancer and Prostatic Diseases, 2023, 26 : 403 - 409
  • [22] Impact of compliance on outcomes for patients on active surveillance for prostate cancer.
    Detsky, Jay
    Ghiam, Alireza Fotouhi
    Mamedov, Alexandre
    Commisso, Kristina
    Commisso, Angela
    Klotz, Laurence
    Liu, Stanley K.
    Loblaw, Andrew
    Vesprini, Danny
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [23] Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance
    Shapiro, Daniel D.
    Gregg, Justin R.
    Lim, Amy H.
    Nogueras-Gonzalez, Graciela M.
    Choi, Haesun
    Kang, Hyunseon C.
    Inguillo, Irene A.
    Chapin, Brian F.
    Davis, John W.
    Ward, John F.
    [J]. BJU INTERNATIONAL, 2021, 127 (03) : 340 - 348
  • [24] Active treatment or surveillance in prostate cancer.
    Irani, Jacques
    [J]. PROGRES EN UROLOGIE, 2007, 17 (01): : 98 - 98
  • [25] NECESSITY OF CONFIRMATORY PROSTATE BIOPSY TO INSURE ACCURATE ELIGIBILITY FOR ACTIVE SURVEILLANCE
    Motamedinia, Piruz
    RiChard, Jamie
    Hruby, Greg
    DeCastro, G. Joel
    Benson, Mitchell
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E888 - E888
  • [26] Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer
    L-M Wong
    S Ferrara
    S M H Alibhai
    A Evans
    T Van der Kwast
    G Trottier
    N Timilshina
    A Toi
    G Kulkarni
    R Hamilton
    A Zlotta
    N Fleshner
    A Finelli
    [J]. Prostate Cancer and Prostatic Diseases, 2015, 18 : 69 - 74
  • [27] Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer
    Wong, L-M
    Ferrara, S.
    Alibhai, S. M. H.
    Evans, A.
    Van der Kwast, T.
    Trottier, G.
    Timilshina, N.
    Toi, A.
    Kulkarni, G.
    Hamilton, R.
    Zlotta, A.
    Fleshner, N.
    Finelli, A.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2015, 18 (01) : 69 - 74
  • [28] Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
    Jayadevan, Rajiv
    Felker, Ely R.
    Kwan, Lorna
    Barsa, Danielle E.
    Zhang, Haoyue
    Sisk, Anthony E.
    Delfin, Merdie
    Marks, Leonard S.
    [J]. JAMA NETWORK OPEN, 2019, 2 (09)
  • [29] The importance of confirmatory biopsy in patients under active surveillance for prostate cance
    Galloway, Peter
    Heywood, Sean
    Chong, Peter
    Blatt, Alison
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 148 - 148
  • [30] MODELS INTEGRATING MRI PREDICT PROSTATE CANCER UPGRADING ON CONFIRMATORY BIOPSY IN ACTIVE SURVEILLANCE PATIENTS
    Barashi, Nimrod S.
    Golan, Shay
    Wang, Chi
    Hirschhorn, Kimberly
    Petkewicz, Jacqueline
    Silvers, Robert
    Thakrar, Kiran
    Eggener, Scott E.
    Helfand, Brian T.
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E141 - E141
12345